Table 4. Effect of the infection control nurse on the sites of community-acquired and healthcare-acquired P. aeruginosa infections.
Community-acquired infections (n = 18) | p value | Healthcare-acquired infections (n = 112) | P value | |||
---|---|---|---|---|---|---|
A(2007–2010, n = 8) | B(2011–2013, n = 10) | A(2007–2010, n = 70) | B(2011–2013, n = 42) | |||
Lower respiratory tract (n, %) | 1 (12.5%) | 2 (20%) | 0.832004 | 58 (82.86%) | 33 (78.57%) | 0.754632 |
Gastrointestinal tract (n, %) | 6 (75%) | 7 (70%) | 0.768625 | 2 (2.86%) | 3 (7.14%) | 0.554731 |
Central venous catheter (n, %) | 6 (8.57%) | 4 (9.52%) | 0.864132 | |||
Other a (n, %) | 1 (12.5%) | 1 (10%) | 0.557225 | 4 (5.71%) | 2 (4.76%) | 0.828440 |
aOther infections included surgical incisions, trauma wounds, burns, bone/joint, and other sites.